FlowCell Revenue and Competitors
Estimated Revenue & Valuation
- FlowCell's estimated annual revenue is currently $775k per year.
- FlowCell's estimated revenue per employee is $155,000
Employee Data
- FlowCell has 5 Employees.
- FlowCell grew their employee count by -44% last year.
FlowCell's People
| Name | Title | Email/Phone |
|---|
FlowCell Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 65 | 5% | N/A | N/A |
#10 | $16.1M | 104 | 9% | N/A | N/A |
What Is FlowCell?
Microfluidics solutions for biologists seeking to increase physiological relevance of their experiments by enabling perfusion for control of cellular microenvironment or dosing of drugs, as well as specialized seeding for 3D cultures: spheroids, organoids and tumoroids. Analytical solutions include multi-physics modeling of microfluidics for biology and automation of flow cytometry analysis.
keywords:N/A
N/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
-44%
Employee Growth %
N/A
Valuation
N/A
Accelerator
FlowCell News
That product is the FlowCell, a system for measuring the health of a kind of battery called redox flow batteries.
Global Flow Cell Sorter Market 2022 Outlook and COVID-19 Impact Prediction 2028 Beckman Coulter, Bio-Rad Laboratories, Sony Biotechnology,...
A new patent-pending flow cell bioreactor developed at PNNL can purify wastewater (seen here) and generate hydrogen to help fuel the process...
Other Companies in Swampscott
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.8M | 17 | 42% | N/A |
#2 | $2.5M | 17 | -11% | N/A |
#3 | $1.6M | 17 | -41% | N/A |
#4 | $4M | 21 | -70% | N/A |
#5 | $3.2M | 26 | 4% | N/A |